{"id":114833,"date":"2021-05-21T15:47:51","date_gmt":"2021-05-21T15:47:51","guid":{"rendered":"https:\/\/fin2me.com\/?p=114833"},"modified":"2021-05-21T15:47:51","modified_gmt":"2021-05-21T15:47:51","slug":"cathie-woods-ark-invest-buys-over-1-million-shares-of-iovance-bio","status":"publish","type":"post","link":"https:\/\/fin2me.com\/business\/cathie-woods-ark-invest-buys-over-1-million-shares-of-iovance-bio\/","title":{"rendered":"Cathie Wood’s ARK Invest Buys Over 1 Million Shares of Iovance Bio"},"content":{"rendered":"
A couple of the ARK exchange-traded funds run by ETF star Cathie Wood made huge purchases on Thursday. These funds bought over 1 million shares of Iovance Biotherapeutics Inc. (NASDAQ: IOVA) shares on Thursday, as the price of these ETFs rose around 3% on Thursday. Note that these ETFs are still up handily in the last year.<\/p>\n
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 201,664 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 808,642 shares of Iovance. At Thursday\u2019s closing price this would have valued this purchase at $18.9 million. Even though this is a small fraction of the total holdings, every little bit counts. ARKG is up 65%, and ARKK is up 75% in the last year.<\/p>\n
Check out all of ARK Invest\u2019s buys for Thursday:<\/p>\n
Fund<\/th>\n | Ticker<\/th>\n | Company<\/th>\n | Shares<\/th>\n<\/tr>\n<\/thead>\n |
---|---|---|---|
ARKF<\/td>\n | COIN<\/td>\n | COINBASE GLOBAL INC<\/td>\n | 38,220<\/td>\n<\/tr>\n |
ARKF<\/td>\n | KSPILI<\/td>\n | KASPI.KZ\u00a0JSC<\/td>\n | 4,436<\/td>\n<\/tr>\n |
ARKG<\/td>\n | RXRX<\/td>\n | RECURSION PHARMACEUTICALS INC<\/td>\n | 14,440<\/td>\n<\/tr>\n |
ARKG<\/td>\n | ONEM<\/td>\n | 1LIFE HEALTHCARE INC<\/td>\n | 144,563<\/td>\n<\/tr>\n |
ARKG<\/td>\n | SGFY<\/td>\n | SIGNIFY HEALTH INC<\/td>\n | 139,900<\/td>\n<\/tr>\n |
ARKG<\/td>\n | IOVA<\/td>\n | IOVANCE BIOTHERAPEUTICS INC<\/td>\n | 201,664<\/td>\n<\/tr>\n |
ARKG<\/td>\n | CSTL<\/td>\n | CASTLE BIOSCIENCES INC<\/td>\n | 11,536<\/td>\n<\/tr>\n |
ARKG<\/td>\n | CMIIU<\/td>\n | CM LIFE SCIENCES II INC<\/td>\n | 305<\/td>\n<\/tr>\n |
ARKG<\/td>\n | CDXS<\/td>\n | CODEXIS INC<\/td>\n | 1,929<\/td>\n<\/tr>\n |
ARKG<\/td>\n | MASS<\/td>\n | 908 DEVICES INC<\/td>\n | 13,080<\/td>\n<\/tr>\n |
ARKG<\/td>\n | RPTX<\/td>\n | REPARE THERAPEUTICS INC<\/td>\n | 41,780<\/td>\n<\/tr>\n |
ARKK<\/td>\n | PACB<\/td>\n | PACIFIC BIOSCIENCES OF CALIFORNIA INC<\/td>\n | 7,496<\/td>\n<\/tr>\n |
ARKK<\/td>\n | IOVA<\/td>\n | IOVANCE BIOTHERAPEUTICS INC<\/td>\n | 808,642<\/td>\n<\/tr>\n |
ARKK<\/td>\n | EXAS<\/td>\n | EXACT SCIENCES CORP<\/td>\n | 125,929<\/td>\n<\/tr>\n |
ARKK<\/td>\n | COIN<\/td>\n | COINBASE GLOBAL INC<\/td>\n | 216,518<\/td>\n<\/tr>\n |
ARKK<\/td>\n | BEAM<\/td>\n | BEAM THERAPEUTICS INC<\/td>\n | 30,000<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | ACIC<\/td>\n | ATLAS CREST INVESTMENT CORP<\/td>\n | 421,940<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | PATH<\/td>\n | UIPATH INC<\/td>\n | 6,131<\/td>\n<\/tr>\n |
ARKQ<\/td>\n | NIU<\/td>\n | NIU TECHNOLOGIES<\/td>\n | 125,271<\/td>\n<\/tr>\n |
ARKX<\/td>\n | BLDE<\/td>\n | BLADE AIR MOBILITY INC<\/td>\n | 105,037<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24\/7 Wall St., owner of 247wallst.com.<\/p>\n \n\t\t\t<\/p>\n \t\t\t\tALSO READ: Semiconductor Equipment Sell-Off Overdone: Jump on These 5 Stocks Now \t\t\t\t |